Sutton Place Investors LLC Makes New $202,000 Investment in Colgate-Palmolive (NYSE:CL)

Sutton Place Investors LLC bought a new stake in Colgate-Palmolive (NYSE:CLFree Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 2,247 shares of the company’s stock, valued at approximately $202,000.

Several other hedge funds and other institutional investors have also made changes to their positions in CL. Vest Financial LLC increased its stake in Colgate-Palmolive by 25.1% during the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after buying an additional 74,337 shares during the period. Central Bank & Trust Co. raised its position in shares of Colgate-Palmolive by 22.1% in the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after purchasing an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC raised its position in shares of Colgate-Palmolive by 9.2% in the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock valued at $864,000 after purchasing an additional 910 shares in the last quarter. Sarasin & Partners LLP boosted its stake in shares of Colgate-Palmolive by 1.2% during the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock valued at $323,115,000 after buying an additional 49,980 shares during the last quarter. Finally, Cornerstone Wealth Management LLC grew its position in shares of Colgate-Palmolive by 2.5% during the fourth quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after buying an additional 172 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Ratings Changes

CL has been the subject of several research reports. Bank of America lifted their target price on Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target on the stock in a research report on Monday, January 29th. Royal Bank of Canada boosted their price objective on Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a research report on Monday. Barclays increased their target price on Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Finally, Evercore ISI boosted their price target on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $91.44.

Get Our Latest Stock Analysis on CL

Insider Buying and Selling at Colgate-Palmolive

In other news, Director C Martin Harris sold 2,760 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the transaction, the director now owns 19,272 shares of the company’s stock, valued at approximately $1,628,484. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider Jennifer Daniels sold 61,633 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $83.93, for a total value of $5,172,857.69. Following the transaction, the insider now owns 57,948 shares of the company’s stock, valued at approximately $4,863,575.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director C Martin Harris sold 2,760 shares of the company’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the sale, the director now directly owns 19,272 shares of the company’s stock, valued at $1,628,484. The disclosure for this sale can be found here. In the last three months, insiders sold 232,371 shares of company stock valued at $19,505,099. 0.37% of the stock is owned by insiders.

Colgate-Palmolive Price Performance

Shares of NYSE CL traded up $1.41 during mid-day trading on Tuesday, reaching $91.90. 5,286,250 shares of the company traded hands, compared to its average volume of 4,616,837. The firm has a market cap of $75.54 billion, a PE ratio of 29.08, a price-to-earnings-growth ratio of 3.42 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a current ratio of 0.42 and a quick ratio of 0.28. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $92.25. The stock has a fifty day simple moving average of $87.95 and a 200-day simple moving average of $81.92.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.04. The company had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period last year, the firm earned $0.73 EPS. Equities research analysts anticipate that Colgate-Palmolive will post 3.5 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, April 19th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.18%. Colgate-Palmolive’s payout ratio is 63.29%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.